Cargando…

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia

BACKGROUND: Antipsychotics have been used for more than 50 years in the treatment of schizophrenia and many other psychiatric disorders. Prolactin levels usually increase in patients treated with risperidone. Aripiprazole, which has a unique effect as an antipsychotic, is a D2 receptor partial agoni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranjbar, Fatemeh, Sadeghi-Bazargani, Homayoun, Niari Khams, Parisa, Arfaie, Asghar, Salari, Azim, Farahbakhsh, Mostafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356449/ https://www.ncbi.nlm.nih.gov/pubmed/25784810 http://dx.doi.org/10.2147/NDT.S69088

Ejemplares similares

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
por: Zhao, Jingyuan, et al.
Publicado: (2015)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia
por: Lin, Chih-Hsun, et al.
Publicado: (2012)

Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies
por: Stojkovic, Milena, et al.
Publicado: (2022)

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018)

Aripiprazole-induced Hyperprolactinemia in a Young Female with Delusional Disorder
por: Joseph, Sam Padamadan
Publicado: (2016)

Management of risperidone-induced hyperprolactinemia in children: a case report
por: Belhadga, H., et al.
Publicado: (2023)

Comparison the effectiveness of aripiprazole and risperidone for the treatment of acute bipolar mania
por: Rezayat, Amir Akhavan, et al.
Publicado: (2014)

Classification of Drugs Listed in Iranian Pharmacopoeia Based on Impact on Driving Performance
por: Farahbakhsh, Mostafa, et al.
Publicado: (2019)

Personality patterns and Smoking behavior among students in Tabriz, Iran
por: Fakharri, Ali, et al.
Publicado: (2017)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
por: He, Sidi, et al.
Publicado: (2020)

Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Ling, et al.
Publicado: (2021)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew, Yaowaluck, et al.
Publicado: (2015)

Prevention and Control of Non-communicable Diseases in Iranian Population: Life Style Promotion Project Phase II: Study Protocol
por: TABRIZI, Jafar Sadegh, et al.
Publicado: (2018)

Factor structure of the Persian version of general, social, and negative self-consciousness of appearance domains of Derriford Appearance Scale 59: an application in the field of burn injuries
por: Sadeghi-Bazargani, Homayoun, et al.
Publicado: (2017)

Emotional distress and its predictors in burn patients
por: Sadeghi-Bazargani, Homayoun, et al.
Publicado: (2019)

The Short-Term Effects of Risperidone-Induced Hyperprolactinemia on Lipid Metabolism in Drug-Naïve Children and Adolescents
por: Park, Eun Jin, et al.
Publicado: (2015)

Lifestyle Risk Factor Assessment Through WHO STEP Approach in Tabriz, Iran
por: Golestani, Mina, et al.
Publicado: (2021)

The Effect of Ranitidine on Olanzapine-Induced Weight Gain
por: Ranjbar, Fatemeh, et al.
Publicado: (2013)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

Prevalence and Associated Factors of Prehypertension and Hypertension in Iranian Population: The Lifestyle Promotion Project (LPP)
por: Tabrizi, Jafar Sadegh, et al.
Publicado: (2016)

Socio-demographic Determinants of Household Food Insecurity among Iranian: A Population-based Study from Northwest of Iran
por: TABRIZI, Jafar Sadegh, et al.
Publicado: (2018)

Prevalence and Associated Factors of Overweight or Obesity and Abdominal Obesity in Iranian Population: A Population-based Study of Northwestern Iran
por: TABRIZI, Jafar Sadegh, et al.
Publicado: (2018)

Psychometric properties of primary health care trust questionnaire
por: Sadeghi-Bazargani, Homayoun, et al.
Publicado: (2019)

Forty years after Alma-Ata: how people trust primary health care?
por: Sadeghi Bazargani, Homayoun, et al.
Publicado: (2020)

A systematic review and meta-analysis of studies on screening for mild cognitive impairment in primary healthcare
por: Karimi, Leila, et al.
Publicado: (2022)

The protocol for validating phone interview tools on post-discharge consequences of road traffic injuries
por: Marin, Soudabeh, et al.
Publicado: (2020)

Psychometric properties of the 12-item WHODAS applied through phone survey: an experience in PERSIAN Traffic Cohort
por: Shahedifar, Nasrin, et al.
Publicado: (2022)

A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia
por: Pandey, Ravi S., et al.
Publicado: (2017)

Effectiveness of the Health Complex Model in Iranian primary health care reform: the study protocol
por: Tabrizi, Jafar Sadegh, et al.
Publicado: (2016)

Health services utilisation and responsiveness profiles in Iran: a provincial household study
por: Farahbakhsh, Mostafa, et al.
Publicado: (2019)

Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study
por: Gianfrancesco, Frank D, et al.
Publicado: (2009)

Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
por: Racki, Valentino, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_umams1q3tm7uc09njal5toalp1